Genetic and epigenetic factors in etiology of diabetes mellitus type 1

Pediatrics

Volumn 132, Issue 6, 2013, Pages 1112-1122

  Stankov, Karmen ^a   Benc, Damir ^a   Draskovic, Dragan ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Diabetes mellitus; Epigenetics; Etiology; Genetics; Type 1

Indexed keywords

DNA; HISTONE; HLA ANTIGEN; GENETIC MARKER; HLA D ANTIGEN;

AUTOIMMUNE DISEASE; DIABETOGENESIS; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HISTONE MODIFICATION; HLA GENE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LINKAGE ANALYSIS; MONOZYGOTIC TWINS; MULTIFACTORIAL GENETIC DISORDER; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS;

DIABETES MELLITUS, TYPE 1; EPIGENESIS, GENETIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-D ANTIGENS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84890774986     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1652     Document Type: Review

References (90)

1. Hakonarson H, Grant S. Genome-wide association studies (GWAS): impact on elucidating the aetiology of diabetes. Diabetes Metab Res Rev. 2011;27(7):685-696
2. Forlenza GP, Rewers M. The epidemic of type 1 diabetes: what is it telling us? Curr Opin Endocrinol Diabetes Obes. 2011;18(4): 248-251
3. Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev. 2010;9(5):A355-A365
4. Jarosz-Chobot P, Polanska J, Szadkowska A, et al. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia. 2011;54(3): 508-515
5. Bruno G, Maule M, Merletti F, et al RIDI Study Group. Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study. Diabetes. 2010;59(9):2281-2287
6. Ehehalt S, Dietz K, Willasch AM, Neu A; Baden- Württemberg Diabetes Incidence Registry (DIARY) Group. Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany: 20 years of the Baden- Württemberg Diabetes Incidence Registry (DIARY). Diabetes Care. 2010;33(2):338-340
7. Diaz-Horta O, Baj A, Maccari G, Salvatoni A, Toniolo A. Enteroviruses and causality of type 1 diabetes: how close are we? Pediatr Diabetes. 2012;13(1):92-99
8. Polychronakos C, Li Q. Understanding type 1 diabetes through genetics: Advances and prospects. Nat Rev Genet. 2011;12(11):781-792
9. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet. 2009;373(9680):2027-2033
10. Thomas IH, Pietropaolo M. Type 1 diabetes: A genetic Pandora's box? Pediatr Diabetes. 2010;11(8):511-512
11. Sugihara S. Genetic susceptibility of childhood type 1 diabetes mellitus in Japan. Pediatr Endocrinol Rev. 2012;10(Suppl 1):62-71
12. Cernea S, Dobreanu M, Raz I. Prevention of type 1 diabetes: Today and tomorrow. Diabetes Metab Res Rev. 2010;26(8):602-605
13. Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008;29(6):697-725
14. Dang MN, Buzzetti R, Pozzilli P. Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev. 2013; 29(1):8-18
15. Groop L, Pociot F. Genetics of diabetes: Are we missing the genes or the disease? Mol Cell Endocrinol. 2013. doi:10.1016/ j.mce.2013.04.002
16. Nejentsev S, Howson JM, Walker NM, et al Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007;450(7171): 887-892
17. Nepom GT, Buckner JH. A functional framework for interpretation of genetic associations in T1D. Curr Opin Immunol. 2012;24(5):516-521
18. Morahan G. Insights into type 1 diabetes provided by genetic analyses. Curr Opin Endocrinol Diabetes Obes. 2012;19(4):263-270
19. Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what's next? Diabetes. 2010;59(7):1561-1571
20. Moore JH, Asselbergs FW, Williams SM. Bioinformatics challenges for genome-wide association studies. Bioinformatics. 2010; 26(4):445-455
21. Clayton DG. Prediction and interaction in complex disease genetics: Experience in type 1 diabetes. PLoS Genet. 2009;5(7): E1000540
22. Smyth DJ, Cooper JD, Howson JM, et al. PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes. Diabetes. 2008;57(6): 1730-1737
23. Eichler EE, Flint J, Gibson G, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010;11(6):446-450
24. Soon WW, Hariharan M, Snyder MP. Highthroughput sequencing for biology and medicine. Mol Syst Biol. 2013;9:640
25. Thomas HE, Kay TW. Intracellular pathways of pancreatic b-cell apoptosis in type 1 diabetes. Diabetes Metab Res Rev. 2011;27 (8):790-796
26. Culina S, Brezar V, Mallone R. Insulin and type 1 diabetes: immune connections. Eur J Endocrinol. 2013;168(2):R19-R31
27. Roggli E, Britan A, Gattesco S, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes. 2010;59(4):978-986
28. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNArelated disease? Transl Res. 2011;157(4): 253-264
29. Nokoff N, Rewers M. Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci. 2013;1281:1-15
30. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA. 2007;104(43): 17040-17045
31. Ounissi-Benkalha H, Polychronakos C. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med. 2008;14(6):268-275
32. Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Tse HM. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci. 2013;1281:16-35
33. Zhong J, Rao X, Xu JF, Yang P, Wang CY. The role of endoplasmic reticulum stress in autoimmune-mediated beta-cell destruction in type 1 diabetes. Exp Diabetes Res. 2012. doi:10.1155/2012/238980
34. Eizirik DL, Miani M, Cardozo AK. Signalling danger: Endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia. 2013; 56(2):234-241
35. Stankov K. Genetic predisposition for type 1 diabetes mellitus: The role of endoplasmic reticulum stress in human disease etiopathogenesis. J Med Biochem. 2010;29 (3):139-149
36. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8(7): 519-529
37. Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006;86(4):1133-1149
38. Melki I, Lambot K, Jonard L, et al. Mutation in the SLC29A3 gene: A new cause of a monogenic, autoinflammatory condition. Pediatrics. 2013;131(4). Available at: www. pediatrics.org/cgi/content/full/131/4/e1308
39. Boettcher C, Brosig B, Zimmer KP, Wudy SA. The subtle signs of Wolfram (DIDMOAD) syndrome: not all juvenile diabetes is type 1 diabetes. J Pediatr Endocrinol Metab. 2011;24(1-2):71-74
40. Torres JM, Cox NJ, Philipson LH. Genome wide association studies for diabetes: Perspective on results and challenges. Pediatr Diabetes. 2013;14(2):90-96
41. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue KC. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2009;10 (Suppl 12):33-42
42. Kumar S. Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes. 2010;11(1):28-37
43. Zalloua PA, Azar ST, Delépine M, et al. WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon. Hum Mol Genet. 2008;17(24):4012-4021
44. Girard D, Petrovsky N. Alström syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol. 2011;7(2): 77-88
45. Senée V, Vattem KM, Delépine M, et al. Wolcott-Rallison syndrome: Clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes. 2004;53(7):1876-1883
46. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis. 2010;5:29
47. Grant SFA, Hakonarson H, Schwartz S. Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? Endocr Rev. 2010;31(2):183-193
48. Gillespie KM. Type 1 diabetes: Pathogenesis and prevention. CMAJ. 2006;175(2):165-170
49. Erlich H, Valdes AM, Noble J, et al; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes. 2008;57(4):1084-1092
50. Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark A. Effects of the second HLA-DQ haplotype on theassociation with childhood insulindependent diabetes mellitus. Tissue Antigens. 1995;45(2):148-152
51. Pugliese A, Gianani R, Moromisato R, et al. HLA-DQB1 0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes. 1995;44(6):608-613
52. Hathout EH, Hartwick N, Fagoaga OR, et al. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Pediatrics. 2003;111(4 pt 1):860-863
53. Todd JA, Walker NM, Cooper JD, et al; Genetics of Type 1 Diabetes in Finland; Wellcome Trust Case Control Consortium. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7): 857-864
54. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145): 661-678
55. Grant SF, Qu HQ, Bradfield JP, et al DCCT/ EDIC Research Group. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes. 2009;58(1):290-295
56. Barrett JC, Clayton DG, Concannon P, et al; Type 1 Diabetes Genetics Consortium. Genome-wide association study and metaanalysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41(6):703-707
57. Mohlke KL, Scott LJ. What will diabetes genomes tell us? Curr Diab Rep. 2012;12(6): 643-650
58. Hu X, Daly M. What have we learned from six years of GWAS in autoimmune diseases, and what is next? Curr Opin Immunol. 2012; 24(5):571-575
59. Bradfield JP, Qu HQ, Wang K, et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 2011;7(9):e1002293
60. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324 (5925):387-389
61. Senée V, Chelala C, Duchatelet S, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006;38(6):682-687
62. Fung EY, Smyth DJ, Howson JM, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/ TNFAIP3 as a susceptibility locus. Genes Immun. 2009;10(2):188-191
63. Sirota M, Schaub MA, Batzoglou S, Robinson WH, Butte AJ. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet. 2009;5(12): E1000792
64. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: Challenges and strategies. Nat Rev Genet. 2013;14(7):483-495
65. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009;10(1):43-55
66. Richard-Miceli C, Criswell LA. Emerging patterns of genetic overlap across autoimmune disorders. Genome Med. 2012;4(1):6
67. Eyre S, Hinks A, Bowes J, et al Yorkshire Early Arthritis Consortium; Biologics in RA Control Consortium. Overlapping genetic susceptibility variants between three autoimmune disorders: Rheumatoid arthritis, type 1 diabetes and coeliac disease. Arthritis Res Ther. 2010;12(5):R175
68. Cotsapas C, Voight BF, Rossin E, et al FOCiS Network of Consortia. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011;7(8):e1002254
69. Herold KC, Vignali DA, Cooke A, Bluestone JA. Type 1 diabetes: Translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol. 2013;13(4):243-256
70. Grinberg-Bleyer Y, Baeyens A, You S, et al. IL- 2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med. 2010;207(9): 1871-1878
71. Stanford SM, Krishnamurthy D, Falk MD, et al. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem. 2011;54(6):1640-1654
72. Lehner B. Genotype to phenotype: lessons from model organisms for human genetics. Nat Rev Genet. 2013;14(3):168-178
73. Freedman ML, Monteiro AN, Gayther SA, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011;43(6):513-518
74. Jiménez-Chillarón JC, Díaz R, Martínez D, et al. The role of nutrition on epigenetic modifications and their implications on health. Biochimie. 2012;94(11): 2242-2263
75. Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. 2012;19(2):93-96
76. Boerner BP, Sarvetnick NE. Type 1 diabetes: Role of intestinal microbiome in humans and mice. Ann N Y Acad Sci. 2011;1243:103-118
77. MacFarlane AJ, Strom A, Scott FW. Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm Genome. 2009;20(9-10): 624-632
78. Williams KT, Garrow TA, Schalinske KL. Type I diabetes leads to tissue-specific DNA hypomethylation in male rats. J Nutr. 2008; 138(11):2064-2069
79. Fradin D, Le Fur S, Mille C, et al. Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PLoS ONE. 2012;7(5):e36278
80. Husseiny MI, Kuroda A, Kaye AN, Nair I, Kandeel F, Ferreri K. Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes. PLoS ONE. 2012;7(10):e47942
81. Rakyan VK, Beyan H, Down TA, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet. 2011;7(9):e1002300
82. Castel SE, Martienssen RA. RNA interference in the nucleus: Roles for small RNAs in transcription, epigenetics and beyond. Nat Rev Genet. 2013;14(2):100-112
83. Guay C, Jacovetti C, Nesca V, Motterle A, Tugay K, Regazzi R. Emerging roles of noncoding RNAs in pancreatic b-cell function and dysfunction. Diabetes Obes Metab. 2012;14(suppl 3):12-21
84. Erener S, Mojibian M, Fox JK, Denroche HC, Kieffer TJ. Circulating miR-375 as a biomarker of b-cell death and diabetes in mice. Endocrinology. 2013;154(2):603-608
85. Nielsen LB, Wang C, Sørensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: Evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res. 2012;2012:896362
86. Sebastiani G, Grieco FA, Spagnuolo I, Galleri L, Cataldo D, Dotta F. Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes Metab Res Rev. 2011;27(8):862-866
87. Hezova R, Slaby O, Faltejskova P, et al. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol. 2010;260(2):70-74
88. Kissler S, Stern P, Takahashi K, Hunter K, Peterson LB, Wicker LS. In vivo RNA interference demonstrates a role for Nramp1 inmodifying susceptibility to type 1 diabetes. Nat Genet. 2006;38(4):479-483
89. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: An epigenetic study in diabetes. Diabetes. 2008;57(12):3189-3198
90. Miao F, Chen Z, Zhang L, et al. Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes. J Biol Chem. 2012;287(20):16335-16345